IL148784A0 - Treating endometriosis or infertility, or improving fertility - Google Patents

Treating endometriosis or infertility, or improving fertility

Info

Publication number
IL148784A0
IL148784A0 IL14878400A IL14878400A IL148784A0 IL 148784 A0 IL148784 A0 IL 148784A0 IL 14878400 A IL14878400 A IL 14878400A IL 14878400 A IL14878400 A IL 14878400A IL 148784 A0 IL148784 A0 IL 148784A0
Authority
IL
Israel
Prior art keywords
infertility
treating endometriosis
improving fertility
fertility
improving
Prior art date
Application number
IL14878400A
Other languages
English (en)
Original Assignee
Columbia Lab Bermuda Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Columbia Lab Bermuda Ltd filed Critical Columbia Lab Bermuda Ltd
Publication of IL148784A0 publication Critical patent/IL148784A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
IL14878400A 1999-10-05 2000-10-04 Treating endometriosis or infertility, or improving fertility IL148784A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15775499P 1999-10-05 1999-10-05
US66838400A 2000-09-25 2000-09-25
PCT/EP2000/009708 WO2001024788A2 (en) 1999-10-05 2000-10-04 Treating endometriosis or infertility, or improving fertility

Publications (1)

Publication Number Publication Date
IL148784A0 true IL148784A0 (en) 2002-09-12

Family

ID=26854456

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14878400A IL148784A0 (en) 1999-10-05 2000-10-04 Treating endometriosis or infertility, or improving fertility
IL148784A IL148784A (en) 1999-10-05 2002-03-20 Use of an adrenergic cell agonist to produce a drug to treat endometrial disease or infertility or improve fertility

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL148784A IL148784A (en) 1999-10-05 2002-03-20 Use of an adrenergic cell agonist to produce a drug to treat endometrial disease or infertility or improve fertility

Country Status (28)

Country Link
EP (1) EP1220667B1 (es)
JP (2) JP2003510354A (es)
KR (1) KR100738724B1 (es)
CN (1) CN1218694C (es)
AR (1) AR028487A1 (es)
AT (1) ATE271860T1 (es)
AU (1) AU780736B2 (es)
BR (1) BR0014548A (es)
CA (1) CA2385974C (es)
CO (1) CO5251423A1 (es)
DE (1) DE60012554T2 (es)
DK (1) DK1220667T3 (es)
ES (1) ES2223581T3 (es)
GE (1) GEP20043313B (es)
HK (1) HK1044120B (es)
HU (1) HU225990B1 (es)
IL (2) IL148784A0 (es)
MA (1) MA25501A1 (es)
MX (1) MXPA02003453A (es)
MY (1) MY129518A (es)
NO (1) NO329663B1 (es)
NZ (1) NZ518429A (es)
PE (1) PE20010742A1 (es)
PT (1) PT1220667E (es)
TR (1) TR200200899T2 (es)
TW (1) TWI280877B (es)
UA (1) UA74168C2 (es)
WO (1) WO2001024788A2 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8425892B2 (en) 2001-10-29 2013-04-23 Columbia Laboratories, Inc. Extended, controlled-release pharmaceutical compositions using charged polymers
CN101327326A (zh) * 2001-10-29 2008-12-24 哥伦比亚实验室(百慕大群岛)有限公司 阴道给药治疗骨盆痛和不孕症的抗节律障碍剂
ES2237298B1 (es) 2003-07-16 2006-11-01 Italfarmaco, S.A. Formulaciones mucoadhesivas semisolidas.
EP1872775A1 (en) 2006-06-29 2008-01-02 Polichem S.A. Use of a hydrophilic matrix comprising a polyacrylic acid derivative, a cellulose ether and a disintegrant for the manufacture of a medicament for treating female genital disorders
ES2344673B1 (es) 2008-08-07 2011-05-03 Italfarmaco, S.A. Uso de estriol en la preparacion de una formulacion farmaceutica parael tratamiento de atrofia vaginal en mujeres con riesgo de potologiatumoral.
ES2344675B1 (es) 2008-12-19 2011-04-28 Italfarmaco, S.A. Uso de estriol en la preparacion de una formulacion farrmaceutica para el tratamiento de atrofia vaginal en mujeres con riesgo de patologiacardiovascular.
CA2793712A1 (en) * 2010-03-22 2011-09-29 Repros Therapeutics Inc. Compositions and methods for non-toxic delivery of antiprogestins
KR101010031B1 (ko) * 2010-12-08 2011-01-21 류상범 흡수식 냉온수기용 엘리미네이터
MX363640B (es) 2012-05-31 2019-03-28 Repros Therapeutics Inc Formulaciones y metodos para la administracion vaginal de antiprogestinas.
EP2914268B1 (en) 2012-11-02 2018-07-04 Repros Therapeutics Inc. Methods and compositions for treating progesterone-dependent conditions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4241087A (en) * 1979-04-02 1980-12-23 William H. Rorer, Inc. Dysmenorrhea treatment
JPH03202769A (ja) * 1989-03-07 1991-09-04 Adeza Biomedical Corp 子宮内膜症診断の方法及び試薬
JP2602456B2 (ja) * 1990-04-12 1997-04-23 雪印乳業株式会社 子宮内膜症治療剤
IT1251114B (it) * 1991-07-26 1995-05-04 Farcon Ag Forme farmaceutiche antivirali per applicazione vaginale
DE69819748T2 (de) * 1997-09-12 2004-09-30 Columbia Laboratories (Bermuda) Ltd. Arzneimittel zur behandlung von dysmenorrhöe und verfrühten wehen

Also Published As

Publication number Publication date
MY129518A (en) 2007-04-30
HK1044120A1 (en) 2002-10-11
AR028487A1 (es) 2003-05-14
HU225990B1 (en) 2008-02-28
UA74168C2 (uk) 2005-11-15
CO5251423A1 (es) 2003-02-28
ATE271860T1 (de) 2004-08-15
DE60012554T2 (de) 2005-11-24
WO2001024788A3 (en) 2001-12-06
NO20021591L (no) 2002-05-28
NZ518429A (en) 2004-02-27
DK1220667T3 (da) 2004-12-06
KR100738724B1 (ko) 2007-07-12
BR0014548A (pt) 2002-06-04
CN1377264A (zh) 2002-10-30
HK1044120B (zh) 2004-12-17
WO2001024788A2 (en) 2001-04-12
KR20020062285A (ko) 2002-07-25
TWI280877B (en) 2007-05-11
AU780736B2 (en) 2005-04-14
TR200200899T2 (tr) 2002-07-22
AU7525000A (en) 2001-05-10
JP2010018639A (ja) 2010-01-28
PT1220667E (pt) 2004-11-30
ES2223581T3 (es) 2005-03-01
CA2385974C (en) 2010-01-26
GEP20043313B (en) 2004-03-10
CN1218694C (zh) 2005-09-14
EP1220667B1 (en) 2004-07-28
JP2003510354A (ja) 2003-03-18
NO329663B1 (no) 2010-11-29
HUP0203050A2 (hu) 2003-02-28
DE60012554D1 (de) 2004-09-02
PE20010742A1 (es) 2001-07-19
NO20021591D0 (no) 2002-04-04
EP1220667A2 (en) 2002-07-10
CA2385974A1 (en) 2001-04-12
MA25501A1 (fr) 2002-07-01
HUP0203050A3 (en) 2006-02-28
IL148784A (en) 2006-12-31
MXPA02003453A (es) 2002-08-20

Similar Documents

Publication Publication Date Title
ZA200108083B (en) Compositions for improving fertility.
IL141063A0 (en) Fsh mimetics for the treatment of infertility
GB9917851D0 (en) Process
HK1039157A1 (zh) 氯化筒箭毒碱調節區、核苷酸序列測定及其使用的方法
IL148784A0 (en) Treating endometriosis or infertility, or improving fertility
GB9924285D0 (en) Process
GB9905512D0 (en) Process
GB9908814D0 (en) Process
HK1029524A1 (en) Base for suppository.
ZA200202182B (en) Treating endometriosis or infertility, or improving fertility.
GB9904162D0 (en) Process
GB9914209D0 (en) Process
PL342098A1 (en) Pharmacological compositions for treating diskineses
GB9914600D0 (en) Novel,process
GB9905418D0 (en) Process
GB9917330D0 (en) Process
GB9903087D0 (en) Process
GB2339263B (en) Restraining link
ZA200205558B (en) Use of FSH treating infertility.
GB9920937D0 (en) Process
GB9909973D0 (en) Process
ZA200003273B (en) Process.
ZA200006886B (en) Method for treating migraine symptoms.
AU2000248011A1 (en) Infertility or increasing fertility
ZA991549B (en) 2-Arylethyl-(piperidin-4-ylmethyl)amine derivatives.

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed